Crohn's Disease

Most recent articles

A 47-year-old man with neuro-Sweet syndrome in association with Crohn’s disease: a case report

Introduction Sweet’s syndrome is a multi-system neutrophilic disease first described by Dr. Robert Douglas Sweet in 1964 [1] and is also known as...

Can Antidepressants Influence the Course of Inflammatory Bowel Disease? The Current State of Research

Inflammatory bowel disease (IBD) is a generic term used to describe a group of chronic and relapsing inflammatory disorders of the gastrointestinal...

The Most Significant Advances in the Management of Crohn’s Disease

Biological Agents Infliximab (a chimaeric humanised anti-tumour necrosis factor [TNF]-α antibody) was the first TNF-α inhibitor approved for the...

Genetics of Inflammatory Bowel Disease

Evidence of Genetic Susceptibility in Disease Pathogenesis There are considerable epidemiological data that implicate genetic susceptibility in the...

Endoscopic Healing as a Therapeutic Target in Crohn’s Disease

Historically, the treatment goals for Crohn’s disease were mainly palliative: to improve symptoms and induce and maintain clinical response and...

Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Gastroenterology is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.